Skip to content

Microdosing: all studies

Page 23 of 56: studies 221 to 230 of 555, newest first. Back to the microdosing overview

Research

Rapid Induction of Buprenorphine/Naloxone for Chronic Pain Using a Microdosing Regimen: A Case Report

A&A Practice January 15, 2020 Danny S. Lee, Jessica E. Hann, Sukhpreet Klaire et al.

Buprenorphine is an effective treatment for chronic pain and may reduce opioid-induced hyperalgesia. However, its pharmacological properties make its induction challenging, time-consuming, and can precipitate opioid withdrawal. We present the case of a 66-year-old woman with inadequately controlled postoperative pain despite escalating doses of oxycodone and methadone, who was successfully...

The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being - An Early Review.

Journal of Psychoactive Drugs 2020 Joel Bornemann

Psychedelic substances are currently experiencing a renaissance in interest for both therapeutic as well as recreational applications. It has been proposed that microdosing, i.e., ingesting sub-perceptual doses of a psychedelic, could confer some of the benefits of these substances to users while minimizing the risks associated with full-dose use. This review aimed to summarize and examine the...

The therapeutic potential of microdosing psychedelics in depression

Therapeutic Advances in Psychopharmacology 2020 Kim P. C. Kuypers 83 citations

Microdosing psychedelics is the repeated use of small doses of, for example, lysergic acid diethylamide (LSD) and psilocybin, typically for a few weeks. Despite the popular and scientific attention in recent years, and claims by users that it has therapeutic value in affective disorders like depression, little scientific knowledge is available to back this. The purpose of this review was to...

DOI: 10.1177/2045125320950567 (opens in new tab) Depression economics Pharmacology

Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube

Harm Reduction Journal November 28, 2019 Martin Andersson, Anette Kjellgren 35 citations

Abstract Background Psychedelic microdosing is the trending practice of using tiny repeated doses of psychedelic substances to facilitate a range of supposed benefits. With only a few published studies to date, the subject is still under-researched, and more knowledge is warranted. Social media and internet discussion forums have played a vital role in the growing visibility of the microdosing...

DOI: 10.1186/s12954-019-0333-3 (opens in new tab) Thematic analysis Comprehension Pharmacology Applied psychology

Microdosing psychedelics: Motivations, subjective effects and harm reduction

International Journal of Drug Policy November 25, 2019 Toby Lea, Nicole Amada, Henrik Jungaberle et al. 119 citations

BackgroundIn recent years there has been growing media attention on microdosing psychedelics (e.g., LSD, psilocybin). This refers to people routinely taking small doses of psychedelic substances to improve mental health and wellbeing, or to enhance cognitive performance. Research evidence is currently limited. This paper examines microdosing motivations, dosing practices, perceived short-term...

Sustainable Intensification of Sorghum and Pearl Millet Production by Seed Priming, Seed Treatment and Fertilizer Microdosing under Different Rainfall Regimes in Mali

Agronomy November 12, 2019 Adama Coulibaly, Kamkam Woumou, Jens B. Aune

Sorghum and pearl millet are the most important stable crops in the drylands of West Africa. This four-year study based on two experiments assessed different low-cost methods for intensification of sorghum and millet production under contrasting rainfall conditions in Mali. Experiment 1 assessed the microdosing rates 0, 0.2, 0.4, 0.6 and 0.8 g NPK hill−1 combined with seed priming across four...

Psychedelic Microdosing: A Subreddit Analysis

Journal of Psychoactive Drugs October 24, 2019 Toby Lea, Nicole Amada, Henrik Jungaberle 121 citations

Self-administration of very low doses of psychedelic drugs to improve mental health and wellbeing and enhance cognitive function, known as microdosing, has received recent media attention, but little research has been conducted. We conducted a content analysis of discussions about microdosing from the online forum Reddit. We examined motivations, dosing practices, and perceived benefits and...

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers

Frontiers in Psychiatry September 13, 2019 Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder et al. 78 citations

Background: There is a growing interest in the use of psychedelic substances for health related purposes, including symptom relief for disorders like anxiety, depression, and pain. Although the focus of recent clinical trials has been on high doses of these substances, anecdotal evidence suggests that low (micro) doses are also effective, and may be more suitable for certain conditions....

DOI: 10.3389/fpsyt.2019.00672 (opens in new tab) Anxiety Mental health Depression economics Clinical psychology

Accounting for Microdosing Classic Psychedelics

Journal of Drug Issues August 30, 2019 Blake Beaton, Heith Copes, Megan Webb et al. 13 citations

Microdosing classic psychedelics (e.g., LSD [lysergic acid diethylamide] and psilocybin) is the practice of taking small amounts of these substances to bring about various positive life changes. Little is known about the subjective experiences and perceptions of those who engage in the practice. Accordingly, we use the sociology of accounts as a theoretical framework to explore the ways that...

MICRODOSING PSYCHEDELICS - LSD, WHERE COULD IT GO?

August 14, 2019 S. Penedos, I. Figueiredo, Maria Margarida Magalhães Lopes et al.

BACKGROUNDMicrodosing of psychedelics such as LSD consists in its regular ingestion of a non-hallucinogenic dose. Advocates deny experiencing the typical alterations in consciousness while reporting various long-lasting psychological benefits.It has been under research for treatment of mental health disorders including end-of-life anxiety, drug abuse, and depression. Increased accessibility in...